Loading clinical trials...
Loading clinical trials...
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Conditions
Interventions
Fluzone Quadrivalent vaccine, No Preservative
Fluzone Quadrivalent vaccine, No Preservative
Locations
36
United States
Birmingham, Alabama, United States
Harrisburg, Arkansas, United States
Downey, California, United States
Paramount, California, United States
Sacramento, California, United States
San Diego, California, United States
Start Date
September 23, 2016
Primary Completion Date
March 6, 2017
Completion Date
March 6, 2017
Last Updated
March 29, 2022
NCT07291635
NCT06094010
NCT06417762
NCT06160128
NCT07396428
NCT07310472
Lead Sponsor
Sanofi Pasteur, a Sanofi Company
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions